XML 56 R38.htm IDEA: XBRL DOCUMENT v3.22.0.1
Summary of Significant Accounting Policies Summary of Significant Accounting Policies (Details Textual)
12 Months Ended
Dec. 31, 2021
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2021
USD ($)
purchaser
Dec. 31, 2021
USD ($)
Dec. 31, 2021
USD ($)
$ / bbl
Dec. 31, 2021
USD ($)
$ / MMBTU
Dec. 31, 2020
USD ($)
Dec. 31, 2020
USD ($)
purchaser
Dec. 31, 2020
USD ($)
Dec. 31, 2020
USD ($)
$ / bbl
Dec. 31, 2020
USD ($)
$ / MMBTU
Dec. 31, 2020
USD ($)
shares
Dec. 31, 2019
USD ($)
Dec. 31, 2019
purchaser
Dec. 31, 2019
Dec. 31, 2019
$ / bbl
Dec. 31, 2019
$ / MMBTU
Dec. 31, 2019
shares
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                                    
Billing date 30 days                                  
Outstanding days of account receivable 60 days                                  
Allowance for doubtful accounts $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0            
Number of purchasers | purchaser     3         2           2        
Capitalized general and administrative costs   38,400,000         30,000,000           $ 31,100,000          
Capitalized interest expense   4,800,000         5,000,000           7,600,000          
Depletion   (310,100,000)         (334,800,000)           (330,700,000)          
Previous period used for price calculation 12 months                                  
Present value discounted percent of future net revenues of proved oil and natural gas reserves       10.00%                            
Average oil and natural gas prices         63.04 3.60       36.04 1.99         52.19 2.58  
Impairment charge of net capitalized costs   0         684,743,000           0          
Stock-based compensation (non-cash) expense   9,039,000         13,625,000           18,505,000          
Common stock and restricted stock unit expense   900,000         1,000,000           1,400,000          
Compensation expense, liability-based awards   20,400,000         4,000,000           3,200,000          
Minimum                                    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                                    
Accounts receivable due period 30 days                                  
Contract term after production 1 month                                  
Maximum                                    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                                    
Accounts receivable due period 60 days                                  
Contract term after production 2 months                                  
Plains Marketing, L.P. | Customer Concentration Risk | Sales Revenue, Goods, Net                                    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                                    
Concentration risk, percentage       29.00%         57.00%           53.00%      
Plains Marketing, L.P. | Customer Concentration Risk | Accounts Receivable                                    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                                    
Concentration risk, percentage       39.00%                            
BP America Production Company | Customer Concentration Risk | Sales Revenue, Goods, Net                                    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                                    
Concentration risk, percentage                 10.00%           14.00%      
BP America Production Company | Customer Concentration Risk | Accounts Receivable                                    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                                    
Concentration risk, percentage                             31.00%      
Exxon Mobil Corporate | Customer Concentration Risk | Sales Revenue, Goods, Net                                    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                                    
Concentration risk, percentage       33.00%         8.00%                  
Exxon Mobil Corporate | Customer Concentration Risk | Accounts Receivable                                    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                                    
Concentration risk, percentage                 35.00%                  
Two Significant Customers | Customer Concentration Risk | Sales Revenue, Goods, Net                                    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                                    
Concentration risk, percentage                 65.00%           67.00%      
Three Significant Customers | Customer Concentration Risk | Sales Revenue, Goods, Net                                    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                                    
Concentration risk, percentage       72.00%                            
Machinery and Equipment                                    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                                    
Capitalized general and administrative costs   $ 1,300,000         1,800,000           1,800,000          
Capitalized interest expense             $ 500,000           $ 900,000          
Useful life using the straight-line 30 years                                  
Machinery and Equipment | Minimum                                    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                                    
Useful life 5 years                                  
Machinery and Equipment | Maximum                                    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                                    
Useful life 30 years                                  
Employee Stock Options                                    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                                    
Antidilutive options excluded from calculation (in shares) | shares                       2,500,000           2,600,000
Restricted Stock                                    
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]                                    
Antidilutive options excluded from calculation (in shares) | shares                       700,000